Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,248 | -2,837 | -2,018 | -2,401 | N/A |
| Other Working Capital | 579 | -462 | 258 | -512 | N/A |
| Other Operating Activity | 1,168 | 258 | 9 | 20 | 0 |
| Operating Cash Flow | $-11,501 | $-3,040 | $-1,750 | $-2,893 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,500 | 2,000 | 1,000 | N/A | N/A |
| Debt Repayment | -3,000 | N/A | N/A | -278 | N/A |
| Common Stock Issued | 43 | 25,121 | N/A | N/A | N/A |
| Other Financing Activity | -83 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,460 | $27,121 | $1,000 | $-278 | $N/A |
| Beginning Cash Position | 24,197 | 116 | 866 | 4,037 | N/A |
| End Cash Position | 14,156 | 24,197 | 116 | 866 | N/A |
| Net Cash Flow | $-10,041 | $24,081 | $-750 | $-3,171 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,501 | -3,040 | -1,750 | -2,893 | N/A |
| Free Cash Flow | -11,501 | -3,040 | -1,750 | -2,893 | 0 |